CORRECTED-Insurer Cigna and Novartis set heart-drug price based on health outcome
February 09, 2016 at 13:55 PM EST
NEW YORK, Feb 8 (Reuters) - U.S.-based health insurer Cigna Corp and Novartis AG have agreed on a performance-based price for the Swiss drugmaker's new heart drug, Entresto, Cigna said on Monday.
